CD Formulation: A New Contract Service Organization of Solid Dosage Form Development for Pharmaceutical Industry
New York, USA- May 17, 2021- Earlier this month, CD Formulation announced the launch of solids dosage forms development service. As a leading excipient manufacturer and formulation development CRO, since its establishment, CD Formulation has always focused on expanding its products and services to meet the growing pharmaceutical needs of customers around the world and to promote the growth of the global pharmaceutical industry.
The solid dosage form is of vital importance for pharmaceuticals, which accounts for about 70% of the preparations of drugs. This dosage form contains one or more therapeutic drugs and excipients, such as binders, sweeteners, and coloring agents. The powders, granules, tablets, and capsules, which are commonly seen or taken by people, all belong to this type of dosage form.
Compared with other dosage forms, solid dosage forms are more stable, more accurate, and do not require complicated storage approaches. In addition, the solid dosage forms are easy to take as well. Patients do not need to measure them, and children can even choose the easily accepted solid dosage forms with flavoring agents. For these advantages, solid dosage forms are usually the first choice for patients.
“For several generations, solid dosage forms have been proven to provide people with effective and time-tested means of treatment,” a spokesperson from CD Formulation said. “Although many innovative dosage forms are gradually entering the market or under development, considering the efficacy and safety, solid dosage forms will still be the dominant part of all dosage forms in the future.”
The solid dosage form development services provided by CD Formulation include:
CD Formulation uses a variety of manufacturing methods, like wet granulation and dry granulation, to ensure an even delivery of active pharmaceutical ingredient (API) in the final tablet.
CD Formulation adopts a number of real-time fill weight monitoring techniques, such as near-infrared spectroscopy (NIR) and vibrational spectroscopy, to guarantee the accuracy of the capsule fill weight.
With powder layering, solution suspension layering and other techniques, CD Formulation converts fine powder or granules of API into smaller, free-flowing units, thereby making the preparation of drugs more flexible.
Equipped with complete and advanced production facilities, CD Formulation has achieved the process development optimization and large-scale production of dosage forms.
Please visit the website https://www.formulationbio.com/solids-dosage-forms.html to learn more.
About CD Formulation
CD Formulation is known worldwide as a leading manufacturer of excipients. Since its founding, CD Formulation has committed to serving the pharmaceutical industry wholeheartedly. The products and services provided by the company cover many aspects, including Crystallinity Determination, Liquid Dosage Form Development, LogP/LogD/pKa Analysis, Amorphous Content Determination and so on. In addition, according to the features of drugs, CD Formulation can provide one-stop services to help customers continuously improve the performance of their products as well.